SCHEMBL28945547

SCHEMBL28945547

CCSC1=N/C(=C\c2ccc3nc(C)sc3c2)C(=O)N1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.58
▸ DYRK1A Q13627 12/20 0.56
▸ DYRK1B Q9Y463 12/20 0.56
▸ DYRK3 O43781 10/20 0.56
▸ DYRK2 Q92630 10/20 0.56
▸ PIM1 P11309 3/20 0.56
▸ CSNK2A2 P19784 3/20 0.56
▸ CSNK2B P67870 3/20 0.56
▸ CSNK2A1 P68400 3/20 0.56
▸ CSNK2A3 Q8NEV1 3/20 0.56
▸ HPGD P15428 2/20 0.56
▸ ALDH1A1 P00352 1/20 0.56
▸ CLK1 P49759 10/20 0.46
▸ CLK4 Q9HAZ1 10/20 0.46
▸ CLK2 P49760 8/20 0.46
▸ CLK3 P49761 4/20 0.46
▸ MAPT P10636 3/20 0.42
▸ GAA P10253 1/20 0.42
▸ DYRK4 Q9NR20 3/20 0.39
▸ GSK3B P49841 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30145008 1.00 KDM4E (0.58) KDM4EDYRK1ADYRK1BDYRK3DYRK2
SCHEMBL30145012 0.88 MAPT (0.56) KDM4EDYRK1ADYRK1BDYRK3DYRK2
SCHEMBL23987070 0.88 MAPT (0.56) KDM4EDYRK1ADYRK1BDYRK3DYRK2
SCHEMBL25590187 0.84 CLK1 (0.52) DYRK1ADYRK1BDYRK3DYRK2PIM1
SCHEMBL30145002 0.81 CLK1 (0.60) KDM4EDYRK1ADYRK1BDYRK3DYRK2
SCHEMBL23510493 0.81 CLK1 (0.60) KDM4EDYRK1ADYRK1BDYRK3DYRK2
SCHEMBL28842886 0.81 CLK1 (0.60) KDM4EDYRK1ADYRK1BDYRK3DYRK2
SCHEMBL24904263 0.78 KDM4E (0.64) KDM4EDYRK1ADYRK1BDYRK3DYRK2
SCHEMBL30363461 0.78 KDM4E (0.64) KDM4EDYRK1ADYRK1BDYRK3DYRK2
SCHEMBL23510596 0.77 KDM4E (0.59) KDM4EDYRK1ADYRK1BDYRK3DYRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115515953-A Novel imidazolidinone derivatives as inhibitors of protein kinases, in particular DYRK1A, CLK1 and/or CLK4 珀哈制药公司 2022-12-23 — — CN disclosed
Send feedback